Medicoeconomic Evaluation of Two Surgical Techniques for Lobectomy in the Lung Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

261 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-07-29

Study Completion Date

2021-10-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a national study that involves the participation of 600 lung cancer patients indicated that treatment is ablation of the pulmonary lobe. This technique is called lobectomy.

Lobectomy may be performed in two different ways:

* Thoracotomy, which is the first reference approach and that is to make a large incision in the chest to pass between the ribs and spread the order to ablate the lobe.
* By video-thoracoscopy, which is a new surgical approach consisting in practice several small incisions in the chest wall to allow the introduction of a camera and special instruments to ablate the lobe.

The mini-invasive nature of video-thoracoscopy has a positive impact on postoperative expectoration and ventilation. As a result, the incidence of postoperative respiratory complications including atelectasis, pneumonia and Acute Respiratory Distress Syndrome (ARDS) is reduced. These respiratory complications are responsible for prolonged stays in Intensive Care Unit (ICU) and overall hospitalisation. It also has an impact on recovery and quality of life when patients return home. The reduction in the incidence of complications should counterbalance the additional cost of video-thoracoscopy.

This study aims to evaluate the effectiveness of these two techniques in relation to the quality of life and the costs they generate.

Patients who agree to participate in the study were assigned to one or other of these groups (technical thoracotomy or video-thoracoscopy technique) by lot.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intraoperative Conversion During Video-assisted Thoracoscopy Resection for Lung Cancer Does Not Alter Survival

NCT04663191

Video-assisted Thoracoscopic Surgery Lung Cancer Lobectomy +2 more

COMPLETED

Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

NCT04937283

Lung Adenocarcinoma

RECRUITING NA

Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

NCT05838053

Lung Adenocarcinoma

RECRUITING

Comparison of Sublobar and Lobectomy in Small (2 Cm or Less 0.5<CTR<1) Non-small Cell Lung Cancer: a Prospective, Multicenter Randomized Controlled Study

NCT06028412

NSCLC, Stage I

ENROLLING_BY_INVITATION NA

Comparison of Segmentectomy Versus Lobectomy for Non-small Cell Lung Cancer ≤ 2 cm in the Middle Third of the Lung Field

NCT04944563

Lung Neoplasms Surgery

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer Lobectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lobectomy or segmentectomy using video-thoracoscopy

Group Type EXPERIMENTAL

Video-thoracoscopy

Intervention Type PROCEDURE

Lobectomy or segmentectomy using thoracotomy

Group Type ACTIVE_COMPARATOR

thoracotomy

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Video-thoracoscopy

Intervention Type PROCEDURE

thoracotomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who have given their consent
* Any patient with proven or suspected lung cancer treated by lobectomy or segmentectomy.
* Patients with a negative mediastinoscopy or negative " EBUS-EUS " following a PET scan showing uptake in mediastinal lymph nodes in the preoperative examination.
* Age ≥ 18 years
* Patient affiliated to a social security regimen
* Patients with a WHO performance status equal to 0 or 1.

Exclusion Criteria

* Adults under wardship
* Pregnant or breast-feeding women
* Tumours in contact with the pulmonary artery or developing in the lobar bronchi after bronchial fibroscopy.
* Tumours in contact with the costal periosteum or invading the chest wall
* Tumours invading the mediastinal pleura or structures of the mediastinium (superior vena cava, trachea, the main-stem bronchi, aorta, oesophagus, vertebrae)
* Tumours invading the diaphragm
* Tumours invading the neurovascular structures of the apex (brachial plexus, subclavicular artery, subclavicular vein) causing Pancoast-Tobias syndrome
* Patients with histologically-proven contralateral or supraclavicular lymph node (N3) involvement whatever the harvesting method.
* Patients with a positive mediastinoscopy or positive "EBUS-EUS" following a "PET scan" with uptake in one or more mediastinal lymph nodes.
* Patients with metastasis (brain, bone, liver, adrenal glands, contralateral lung, pleura).
* Patients who have undergone neo-adjuvant chemotherapy and/or radiotherapy.
* Patients included in a neo-adjuvant chemotherapy and/or radiotherapy protocol.
* Patients who have already undergone thoracotomy.
* Patients with decompensated heart failure or with a systolic ejection fraction below 30%.
* Patients with severe pulmonary artery hypertension.
* Patients with untreated valve disease.
* Patients with unstable angina despite appropriate treatment.
* Patients with untreated carotid stenosis greater than 70%.
* Patients with histologically proven cirrhosis with various decompensations or who have presented haemoptysis because of oesophageal varicose veins.
* Patients with severe neurological sequellae (hemiplegia, paraplegia, tetraplegia).
* Patients presenting severe psychiatric disorders (dementia, psychosis).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No